Prospective Assessment of an Automated Intraprocedural 12-Lead ECG-Based System for Localization of Early Left Ventricular Activation.


Journal

Circulation. Arrhythmia and electrophysiology
ISSN: 1941-3084
Titre abrégé: Circ Arrhythm Electrophysiol
Pays: United States
ID NLM: 101474365

Informations de publication

Date de publication:
07 2020
Historique:
pubmed: 17 6 2020
medline: 11 11 2020
entrez: 16 6 2020
Statut: ppublish

Résumé

To facilitate ablation of ventricular tachycardia (VT), an automated localization system to identify the site of origin of left ventricular activation in real time using the 12-lead ECG was developed. The objective of this study was to prospectively assess its accuracy. The automated site of origin localization system consists of 3 steps: (1) localization of ventricular segment based on population templates, (2) population-based localization within a segment, and (3) patient-specific site localization. Localization error was assessed by the distance between the known reference site and the estimated site. In 19 patients undergoing 21 catheter ablation procedures of scar-related VT, site of origin localization accuracy was estimated using 552 left ventricular endocardial pacing sites pooled together and 25 VT-exit sites identified by contact mapping. For the 25 VT-exit sites, localization error of the population-based localization steps was within 10 mm. Patient-specific site localization achieved accuracy of within 3.5 mm after including up to 11 pacing (training) sites. Using 3 remotes (67.8±17.0 mm from the reference VT-exit site), and then 5 close pacing sites, resulted in localization error of 7.2±4.1 mm for the 25 identified VT-exit sites. In 2 emulated clinical procedure with 2 induced VTs, the site of origin localization system achieved accuracy within 4 mm. In this prospective validation study, the automated localization system achieved estimated accuracy within 10 mm and could thus provide clinical utility.

Sections du résumé

BACKGROUND
To facilitate ablation of ventricular tachycardia (VT), an automated localization system to identify the site of origin of left ventricular activation in real time using the 12-lead ECG was developed. The objective of this study was to prospectively assess its accuracy.
METHODS
The automated site of origin localization system consists of 3 steps: (1) localization of ventricular segment based on population templates, (2) population-based localization within a segment, and (3) patient-specific site localization. Localization error was assessed by the distance between the known reference site and the estimated site.
RESULTS
In 19 patients undergoing 21 catheter ablation procedures of scar-related VT, site of origin localization accuracy was estimated using 552 left ventricular endocardial pacing sites pooled together and 25 VT-exit sites identified by contact mapping. For the 25 VT-exit sites, localization error of the population-based localization steps was within 10 mm. Patient-specific site localization achieved accuracy of within 3.5 mm after including up to 11 pacing (training) sites. Using 3 remotes (67.8±17.0 mm from the reference VT-exit site), and then 5 close pacing sites, resulted in localization error of 7.2±4.1 mm for the 25 identified VT-exit sites. In 2 emulated clinical procedure with 2 induced VTs, the site of origin localization system achieved accuracy within 4 mm.
CONCLUSIONS
In this prospective validation study, the automated localization system achieved estimated accuracy within 10 mm and could thus provide clinical utility.

Identifiants

pubmed: 32538133
doi: 10.1161/CIRCEP.119.008262
pmc: PMC7375941
mid: NIHMS1604783
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e008262

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL126802
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL142496
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL141074
Pays : United States

Références

J Cardiovasc Electrophysiol. 2003 Dec;14(12):1280-6
pubmed: 14678101
Circulation. 1998 Jul 28;98(4):308-14
pubmed: 9711935
J Electrocardiol. 2006 Oct;39(4 Suppl):S87-95
pubmed: 16963072
J Am Coll Cardiol. 2019 Apr 2;73(12):1413-1425
pubmed: 30922472
J Cardiovasc Electrophysiol. 2007 Feb;18(2):161-8
pubmed: 17338765
Circulation. 1981 Aug;64(2):257-72
pubmed: 7249295
JACC Clin Electrophysiol. 2017 Jul;3(7):687-699
pubmed: 29759537
Circulation. 2002 Sep 24;106(13):1678-83
pubmed: 12270862
IEEE Trans Biomed Eng. 2000 May;47(5):682-9
pubmed: 10851812
J Cardiovasc Electrophysiol. 2018 Jul;29(7):979-986
pubmed: 29702740
Europace. 2018 Jan 1;20(1):209-213
pubmed: 29186419
J Am Coll Cardiol. 2006 May 16;47(10):2013-9
pubmed: 16697318
J Electrocardiol. 2018 Sep - Oct;51(5):801-808
pubmed: 30177316
Circulation. 1988 Apr;77(4):759-66
pubmed: 3349580
Heart Rhythm. 2020 Jan;17(1):e2-e154
pubmed: 31085023
J Am Coll Cardiol. 2011 May 31;57(22):2255-62
pubmed: 21616286
J Am Coll Cardiol. 1989 Mar 15;13(4):893-903
pubmed: 2926041
Heart Rhythm. 2020 Apr;17(4):567-575
pubmed: 31669770
IEEE Trans Biomed Eng. 1994 Sep;41(9):830-6
pubmed: 7959810
Ann N Y Acad Sci. 1990;601:128-47
pubmed: 2221684
Circulation. 1993 Nov;88(5 Pt 1):2290-306
pubmed: 8222124
Heart Rhythm. 2019 Mar;16(3):435-442
pubmed: 30385382
IEEE Trans Biomed Eng. 2019 Nov;66(11):3278-3287
pubmed: 30843798
N Engl J Med. 2016 Jul 14;375(2):111-21
pubmed: 27149033
Circ Arrhythm Electrophysiol. 2012 Oct;5(5):1001-9
pubmed: 22923272
N Engl J Med. 2017 Dec 14;377(24):2325-2336
pubmed: 29236642
J Electrocardiol. 2018 Nov - Dec;51(6S):S92-S97
pubmed: 30177365
Heart Rhythm. 2012 Mar;9(3):330-4
pubmed: 22001707
Heart Rhythm. 2015 Jul;12(7):1534-40
pubmed: 25847476
J Am Coll Cardiol. 1994 Dec;24(7):1708-24
pubmed: 7963119
Europace. 2018 Oct 1;20(10):1647-1656
pubmed: 29528391
IEEE Trans Biomed Eng. 2018 Jul;65(7):1662-1671
pubmed: 28952932
Card Electrophysiol Rev. 2002 Dec;6(4):436-41
pubmed: 12438825
Nat Biomed Eng. 2018 Oct;2(10):732-740
pubmed: 30847259

Auteurs

Shijie Zhou (S)

Department of Biomedical Engineering (S.Z., N.A.T.), Johns Hopkins University, Baltimore, MD.
Alliance for Cardiovascular Diagnostic and Treatment Innovation (S.Z., N.A.T.), Johns Hopkins University, Baltimore, MD.
Heart Rhythm Service, Cardiology Division, Department of Medicine, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada (S.Z., A.A., J.S.D., I.E., D.C.L., C.J.M., R.P., C.J.G., M.J.G., C.M., R.C., J.L.S.).

Amir AbdelWahab (A)

Heart Rhythm Service, Cardiology Division, Department of Medicine, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada (S.Z., A.A., J.S.D., I.E., D.C.L., C.J.M., R.P., C.J.G., M.J.G., C.M., R.C., J.L.S.).

B Milan Horáček (BM)

School of Biomedical Engineering (B.M.H.), Dalhousie University, Halifax, NS, Canada.

Paul J MacInnis (PJ)

Departments of Physiology and Biophysics (P.J.M., J.W.W., J.L.S.), Dalhousie University, Halifax, NS, Canada.

James W Warren (JW)

Departments of Physiology and Biophysics (P.J.M., J.W.W., J.L.S.), Dalhousie University, Halifax, NS, Canada.

Jason S Davis (JS)

Heart Rhythm Service, Cardiology Division, Department of Medicine, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada (S.Z., A.A., J.S.D., I.E., D.C.L., C.J.M., R.P., C.J.G., M.J.G., C.M., R.C., J.L.S.).

Ihab Elsokkari (I)

Heart Rhythm Service, Cardiology Division, Department of Medicine, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada (S.Z., A.A., J.S.D., I.E., D.C.L., C.J.M., R.P., C.J.G., M.J.G., C.M., R.C., J.L.S.).

David C Lee (DC)

Heart Rhythm Service, Cardiology Division, Department of Medicine, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada (S.Z., A.A., J.S.D., I.E., D.C.L., C.J.M., R.P., C.J.G., M.J.G., C.M., R.C., J.L.S.).

Ciorsti J MacIntyre (CJ)

Heart Rhythm Service, Cardiology Division, Department of Medicine, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada (S.Z., A.A., J.S.D., I.E., D.C.L., C.J.M., R.P., C.J.G., M.J.G., C.M., R.C., J.L.S.).

Ratika Parkash (R)

Heart Rhythm Service, Cardiology Division, Department of Medicine, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada (S.Z., A.A., J.S.D., I.E., D.C.L., C.J.M., R.P., C.J.G., M.J.G., C.M., R.C., J.L.S.).

Chris J Gray (CJ)

Heart Rhythm Service, Cardiology Division, Department of Medicine, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada (S.Z., A.A., J.S.D., I.E., D.C.L., C.J.M., R.P., C.J.G., M.J.G., C.M., R.C., J.L.S.).

Martin J Gardner (MJ)

Heart Rhythm Service, Cardiology Division, Department of Medicine, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada (S.Z., A.A., J.S.D., I.E., D.C.L., C.J.M., R.P., C.J.G., M.J.G., C.M., R.C., J.L.S.).

Curtis Marcoux (C)

Heart Rhythm Service, Cardiology Division, Department of Medicine, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada (S.Z., A.A., J.S.D., I.E., D.C.L., C.J.M., R.P., C.J.G., M.J.G., C.M., R.C., J.L.S.).

Rajin Choudhury (R)

Heart Rhythm Service, Cardiology Division, Department of Medicine, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada (S.Z., A.A., J.S.D., I.E., D.C.L., C.J.M., R.P., C.J.G., M.J.G., C.M., R.C., J.L.S.).

Natalia A Trayanova (NA)

Department of Biomedical Engineering (S.Z., N.A.T.), Johns Hopkins University, Baltimore, MD.
Alliance for Cardiovascular Diagnostic and Treatment Innovation (S.Z., N.A.T.), Johns Hopkins University, Baltimore, MD.

John L Sapp (JL)

Heart Rhythm Service, Cardiology Division, Department of Medicine, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada (S.Z., A.A., J.S.D., I.E., D.C.L., C.J.M., R.P., C.J.G., M.J.G., C.M., R.C., J.L.S.).
Departments of Physiology and Biophysics (P.J.M., J.W.W., J.L.S.), Dalhousie University, Halifax, NS, Canada.
Medicine (J.L.S.), Dalhousie University, Halifax, NS, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH